Joel Greshock - VP, Oncology, Data Science & Digital Health - Janssen Research & Development

Joel Greshock is VP, Oncology, Data Science & Digital Health, Janssen Research & Development ( https://www.janssen.com/oncology/leadership-team ). In this position, he is responsible for creating unique and actionable medical insights using large and increasingly available datasets. The focus of this research includes discovering novel therapeutic targets, identifying areas of unmet medical need, and enhancing clinical trial recruitment and execution.

Prior to joining Janssen R&D, Joel served as Vice President of Bioinformatics at Neon Therapeutics, Inc., where he built and managed the Data Sciences organization. At Neon, he was responsible for the design and deployment of personalized cancer therapies now under clinical evaluation.

Prior to joining Neon, Joel served as Head of Oncology Translational Informatics for Novartis, where he was responsible for the correlation of patient outcomes with molecular biomarkers, identification of mechanisms of clinical resistance and computational research for assets approaching or being evaluated in early phases of development.

Before joining Novartis, Joel assumed numerous roles for GlaxoSmithKline Oncology, which included Head of Bioinformatics. Earlier in his career, Joel was a Data Analyst at Abramson Family Cancer Research Institute at the University of Pennsylvania, where he built early generation microarray platforms and developed widely used predictive models for cancer predisposition mutations.

Joel holds a Bachelor of Science in Comprehensive Science and a Master of Science in Biology/Biostatistics, both from Villanova University. He also completed studies at the University of Pennsylvania and Temple University in Statistics and Computer Science.